Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Effect of Physical Activity Program on Sedentary of Patients With Upper Aerodigestive Tract Cancer [NA]
A clinical trial is investigating whether a structured physical activity program reduces sedentary behavior in patients with upper aerodiges…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: A Prospective Study of Daily Adaptive Radiotherapy to Better Organ-at-Risk Doses in Head and Neck Cancer [Phase 2]
This update reports the completion of a Phase 2 prospective study evaluating daily adaptive radiotherapy to reduce doses to organs at risk i…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: De-Intensification Radiotherapy Postoperative Head Neck [Phase 2]
This update covers a Phase 2 trial evaluating de-intensification postoperative radiotherapy for head and neck cancer, which has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer
The trial evaluating the role of alcohol and tobacco consumption in patients with head and neck cancer or lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Total-Body FDG PET for Radiotherapy Response Assessment in Head and Neck Cancer [NA]
This update notes the completion of a clinical trial evaluating total-body FDG PET for assessing radiotherapy response in head and neck canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Pea Protein Oral Nutrition Supplement for the Reduction of Gastrostomy Tube Placement Rate in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiation Therapy [NA]
A clinical trial update describes evaluating a pea protein oral nutrition supplement to reduce gastrostomy tube placement in patients with l…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Medical Cannabis During Chemoradiation for Head and Neck Cancer
The document notes the completion of a clinical trial evaluating medical cannabis during chemoradiation for head and neck cancer, providing …
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Pilot Study of Radiation-Induced Xerostomia Treatment With Allogeneic Mesenchymal Stromal Stem Cells [Phase 1]
A Phase 1 pilot study evaluating the safety and feasibility of using allogeneic mesenchymal stromal stem cells to treat radiation-induced xe…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: PentoxIfylline and Tocopherol for the Treatment of Post-radiotherapy Fibrosis in Head and Neck Cancer Patients [Phase 1]
A Phase 1 trial evaluating pentoxifylline plus tocopherol (vitamin E) for post-radiotherapy fibrosis in head and neck cancer patients has co…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Optical Coherence Tomography in Patients With Radiotherapy for Head and Neck Cancer
This clinical trial update reports on the use of optical coherence tomography imaging in patients undergoing radiotherapy for head and neck …
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Trial Comparing Different Follow-up Strategies [NA]
A clinical trial comparing different follow-up strategies for head and neck cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer [Phase 3]
A Phase 3 trial evaluating cisplatin with or without an unspecified monoclonal antibody therapy in patients with metastatic or recurrent hea…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Pain Management for Head and Neck Cancer Survivors [NA]
This clinical trial update notes the completion of a study evaluating pain management for head and neck cancer survivors. The sponsor is OHS…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: İnvestigation of the Effect of Neck Endurance on Swallowing and Directional Coordination in Head and Neck Cancer Patients
A completed clinical trial investigated whether neck endurance training affects swallowing and directional coordination in patients with hea…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Virtual Rehabilitation for Cancer Survivors [NA]
A clinical trial update indicates a virtual rehabilitation program for cancer survivors is currently recruiting across multiple cancer types…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: First in Human Study of AZD9592 in Solid Tumors [Phase 1]
First-in-human Phase 1 study of AstraZeneca’s AZD9592 in solid tumors is recruiting to evaluate safety, tolerability, and preliminary dosing…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION) [Phase 3]
Phase III XRAY VISION trial evaluating Xevinapant with radiotherapy in resected locally advanced head and neck squamous cell carcinoma in ci…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Fecal Microbiota And Metabolites In Head And Neck Cancer Patients Receiving (Chemo)Radiotherapy [NA]
A completed clinical trial evaluating fecal microbiota and metabolites in head and neck cancer patients receiving chemo/radiotherapy.
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors [Phase 1]
Phase 1 study of palbociclib in combination with gedatolisib in patients with advanced solid tumors, including lung squamous cell carcinoma,…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer [Phase 2]
Phase 2 study evaluating tadalafil in combination with pembrolizumab in recurrent or metastatic head and neck cancer has completed enrollmen…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Kaltenborn Versus Active Release on Temporomandibular Joint Dysfunction [NA]
This clinical trial comparing Kaltenborn versus Active Release on temporomandibular joint dysfunction has completed, with head and neck canc…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Nephroprotective Effect of Pentoxifylline Against Cisplatin in Patients With Head and Neck Cancer [NA]
A completed clinical trial update investigates whether pentoxifylline provides nephroprotection against cisplatin-induced kidney injury in p…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers [Phase 1]
Adaptimmune's Phase 1 trial of MAGE-A10 CAR T therapy for urothelial carcinoma, head and neck cancer, and melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Mental Health App for Cancer Survivors Study [NA]
A clinical trial evaluating a mental health app for head and neck cancer survivors with depression was terminated, according to the Universi…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell Surface [Phase 1]
A Phase 1 study evaluating different doses of BI-765049 alone and in combination with Ezabenlimab in patients with advanced solid tumors exp…